Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ADS DiagnosticsBOM:523031 Gross Margin % is 52.17% as of Mar. 2026, which is 5% above its 10-year median of 49.48. The stock has 3 warning signs investors should review.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
ADS Diagnostics had a gross margin of 52.17% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
ADS Diagnostics Gross Margin % Related Terms
ADS Diagnostics Gross Margin % Historical Data
* Premium members only.
The historical data trend for ADS Diagnostics's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:523031 vs OZSC, WHSI, LENSF: Gross Margin % Comparison
For the Medical Devices subindustry, ADS Diagnostics's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ADS Diagnostics Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ADS Diagnostics's Gross Margin % distribution charts can be found below:
* The bar in red indicates where ADS Diagnostics's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
ADS Diagnostics (BOM:523031) has a Gross Margin % of 52.17% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on ADS Diagnostics and its competitors. This is near median its historical median of 49.48. Over the past decade, ADS Diagnostics' Gross Margin % has ranged from 34.18 to 60.76.
Is ADS Diagnostics' Gross Margin % too high?
ADS Diagnostics' current Gross Margin % of 52.17% is near median its 10-year median of 49.48. Over the past 10 years, this metric has ranged from a low of 34.18 to a high of 60.76. The Medical Devices & Instruments industry median Gross Margin % is 52.12. ADS Diagnostics' value of 52.17% is 0.1% above this industry median.
How does ADS Diagnostics' Gross Margin % compare to OZSC and WHSI?
ADS Diagnostics' Gross Margin % of 52.17% can be compared against companies in the Medical Devices & Instruments industry. The industry median Gross Margin % is 52.12. ADS Diagnostics' value of 52.17% is 0.1% above this benchmark. Historically, ADS Diagnostics' own Gross Margin % has ranged from 34.18 to 60.76 over the past decade. While the company's 10-year median is 49.48 vs. the industry median of 52.12, ADS Diagnostics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.12, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ADS Diagnostics's current Gross Margin % of 52.17% is 0.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on ADS Diagnostics and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ADS Diagnostics's current Gross Margin % is 52.17%, which is near median its own 10-year median of 49.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ADS Diagnostics stock overvalued right now?
ADS Diagnostics (BOM:523031) has a current Gross Margin % of 52.17%. The stock's GF Value™ is ₹11.48, compared to a current price of ₹11.34 — trading 1.2% below its estimated fair value. The current Gross Margin % is 52.17%, which is near median its 10-year median of 49.48 and 0.1% above the Medical Devices & Instruments industry median of 52.12. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For ADS Diagnostics (BOM:523031), the current Gross Margin % is 52.17% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ADS Diagnostics Ltd is an India-based company engaged in the sale of medical equipment. It is focused on the business activity of the sale of trading goods, servicing and installation of medical equipment, lease rental, and distribution. The company generates key revenue from the sale of trading goods. It sells its products and services in India and internationally.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:523031 has been successfully added to your 
